Mindfulness Text Messages to Support Medication Adherence and Pain Management
Official title: Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder and Chronic Pain
Run by University of New Mexico · NCT07711795 · Data updated 2026-11-12
This study tests whether daily reminder and mindfulness text messages can help people on medications for opioid use disorder with chronic pain stick to their treatment and better manage cravings and pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of New Mexico Academic / other |
| Locations | 1 site (Albuquerque, New Mexico) |
| Status | Recruiting |
| Started | April 23, 2025 |
| Main results expected | July 2027 |
| Study ends | October 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07711795 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older residing in the United States, initiating or restarting methadone or buprenorphine treatment, with chronic pain, who own a mobile phone and can access text messaging and study surveys.
✕Probably not a fit
Individuals without access to reliable mobile texting, not on methadone/buprenorphine therapy, or without chronic pain may derive little to no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates two mindfulness text message strategies delivered alongside daily medication reminders for people starting or restarting methadone or buprenorphine treatment and living with chronic pain. Participants receive six weeks of mindfulness messages (two per day in one arm, four per day in another) plus 12 weeks of daily medication reminders, with message timing randomized across six daily windows. The trial examines adherence to medication, cravings, pain and pain interference, mindfulness, and withdrawal symptoms, comparing curriculum-based messages to randomized messages. Engagement with messages, state mindfulness, values-based living, substance misuse, and self-efficacy are secondary outcomes. Sixty adults across the United States will participate, with outcomes assessed through self-reported measures and questionnaires.
Why it matters
Potential benefit: If successful, participants may experience better medication adherence and reduced craving and pain, contributing to improved opioid use disorder management.
How similar studies have gone: Previous work suggests that mHealth text messages can support adherence and symptom management, but this specific dual-message mindfulness curriculum approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Reside in the United States * Own or have access to a mobile phone capable of sending and receiving text messages * Have reliable internet access to complete study surveys * Be willing and able to comply with all study procedures and remain available for the duration of the study * Be interested in receiving medication reminders and mindfulness text messages * Be within 2 months of initiating or restarting methadone or buprenorphine treatment for opioid use * Report chronic pain (pain lasting at least 3 months) * Live in the United States Exclusion Criteria: * None
Where it's running
-
University of New Mexico
Albuquerque, New Mexico, United States Recruiting
Study contacts
- Study coordinator: Frank Schwebel, PhD
- Email: textlabresearch@gmail.com
- Phone: 505-456-3014
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Text reminders and mindfulness messages to support people taking opioid medications
This project will test whether daily medication reminder texts plus up to six mindfulness messages per day help people taking medications for opioid use disorder stick to their medication and manage cravings, pain, and withdrawal.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.